PRESS RELEASE published on 04/30/2025 at 01:20, 1 year ago Electric Metals (USA) Limited Closes $3.0 Million Non-Brokered Private Placement Led by Eric Sprott and Crescat Capital Electric Metals (USA) Limited closes C$3.0 million non-brokered private placement to advance Emily Manganese Project in Minnesota for high-purity manganese sulfate production Private Placement Investors Electric Metals Manganese Project US Supply Chain
PRESS RELEASE published on 04/30/2025 at 00:00, 1 year ago Changements au sein du conseil d'administration: Michiel Allaerts succède à Theo Roussis Changements au sein du conseil d'administration de Ravago et KBC Groupe. Michiel Allaerts succède à Theo Roussis. Nouvelle composition du conseil d'administration et remerciements à Theo Roussis Conseil D'administration KBC Groupe Michiel Allaerts Theo Roussis Ravago
PRESS RELEASE published on 04/30/2025 at 00:00, 1 year ago Wijzigingen in de Raad van Bestuur: Michiel Allaerts volgt Theo Roussis op Michiel Allaerts volgt Theo Roussis op als bestuurder in de Raad van Bestuur van KBC Groep na Algemene Vergadering Algemene Vergadering KBC Groep Raad Van Bestuur Michiel Allaerts Theo Roussis
PRESS RELEASE published on 04/30/2025 at 00:00, 1 year ago Changes in the Board of Directors: Michiel Allaerts succeeds Theo Roussis Michiel Allaerts appointed as new director of Ravago, replacing Theo Roussis. Roussis to step down as non-executive director of KBC Group. Allaerts brings diverse experience to the role Board Of Directors KBC Group Michiel Allaerts Theo Roussis Ravago
PRESS RELEASE published on 04/29/2025 at 23:30, 1 year ago Electric Royalties Announces Marketing Activities and Long-Term Incentive Grants Electric Royalties Ltd. announces marketing activities to increase investor awareness and grants stock options, RSUs, and DSUs. The Company aims to acquire royalties over commodities driving the electric revolution Stock Options Investor Awareness Commodities Electric Royalties Ltd. Marketing Activities
PRESS RELEASE published on 04/29/2025 at 23:30, 1 year ago Atlas Salt Issues Stock Options Atlas Salt Inc. grants 200,000 stock options to a director at 46 cents with 4,384,531 shares remaining for issuance. The search for a new CEO begins with the appointment of Patrick Laracy as interim CEO Stock Options Atlas Salt Inc. Environmental Stewardship CEO Search Mining Firm
PRESS RELEASE published on 04/29/2025 at 23:00, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats Annonce des résultats annuels 2024 du Groupe TERA avec un EBIDTA de 867 k€. Forte croissance des laboratoires et des capteurs. Situation financière satisfaisante pour poursuivre le développement Croissance Résultats Annuels Situation Financière Groupe TERA EBIDTA
PRESS RELEASE published on 04/29/2025 at 22:15, 1 year ago REMINDER: Jaguar Health Hosting April 30 Investor Webcast to Present Initial Results from Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) Jaguar Health investor webcast to review crofelemer impact on MVID and SBS-IF patients. No approved treatments for MVID, study presented by Dr. Miqdady at ELITE PED-GI Congress Investor Webcast Jaguar Health MVID SBS-IF Crofelemer Impact
PRESS RELEASE published on 04/29/2025 at 22:05, 1 year ago Abivax annonce la fin du recrutement des patients dans le cadre de ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH) modérément à sévèrement active Abivax annonce la fin du recrutement des patients pour les essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique. Premiers résultats attendus au T3 2025 Abivax Obefazimod Rectocolite Hémorragique Essais De Phase 3 RCH
PRESS RELEASE published on 04/29/2025 at 22:05, 1 year ago Abivax annonce la fin du recrutement des patients dans le cadre de ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH) modérément à sévèrement active Abivax annonce la fin du recrutement des patients pour ses essais de phase 3 ABTECT dans le traitement de la rectocolite hémorragique (RCH). Premiers résultats attendus T3 2025 Abivax Rectocolite Hémorragique Phase 3 ABTECT RCH
Published on 05/04/2026 at 01:40, 4 hours 41 minutes ago New Head of Corporate Affairs and Sustainability
Published on 05/02/2026 at 21:00, 1 day 9 hours ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 2 days 4 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 2 days 5 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 2 days 6 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/03/2026 at 20:10, 10 hours 11 minutes ago A Decade of Learning Across Borders: PKU's South-South Institute Turns 10
Published on 05/03/2026 at 04:45, 1 day 1 hour ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 14 hours ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 2 days 10 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 21:21, 3 days 8 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 3 days 10 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 3 days 10 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 3 days 11 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 3 days 11 hours ago AXA annonce les résultats de son Assemblée Générale